Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Travere Therapeutics
Pharma
Travere's bid to gain new approval for Filspari hits FDA hitch
After asking for additional information on the drug's clinical benefit a few weeks ago, the FDA has delayed its decision on Filspari to treat FSGS.
Kevin Dunleavy
Jan 14, 2026 11:22am
Chugai strikes $200M deal for IgAN asset in Asian countries
Oct 24, 2025 9:40am
Travere taps Grammy-winning producer to create patient anthem
Jun 10, 2025 12:18pm
Second Novartis drug in IgAN troika crosses FDA finish line
Apr 3, 2025 10:56am
Mirum's Ctexli scores FDA approval in rare metabolic disorder
Feb 21, 2025 3:30pm
Travere pauses trial enrollment over manufacturing scale-up woes
Sep 27, 2024 9:26am
